WHO welcomes Abbott's decision to reduce prices of second-line anti-retroviral therapy

The World Health Organization (WHO) has welcomed Abbott Laboratories decision to significantly reduce the prices of second-line anti-retroviral therapeutics.

In a statement issued here, the WHO also said that it is committed to promoting universal access to HIV prevention services and treatment by 2010.

Praising the growing number of people being treated with antiretroviral therapy (ART), the WHO said this trend was possible because of access to "second-line" ART.

The WHO said it will continue to work with countries, people living with HIV/AIDS, organizations and the pharmaceutical industry, to find mechanisms that address immediate needs.

Source : Netindia